Possibia

326

Last Update Posted: 2017-05-04

Recruiting has ended

All Genders

accepted

18 Years-64 Years

0 Estimated Participants

No Expanded Access

Interventional Study

Does not accept healthy volunteers

Buprenorphine/Naloxone Treatment for Opioid Dependence-Experiment 1 - 1

The purpose of this study is to assess the clinical efficacy of the buprenorphine/naloxone combination tablet for alternate-day dosing and determine whether multiples of the daily dose are necessary to maintain an effective alternate day dosing regimen.

Alternate-day dosing with the 8mg buprenorphine-naloxone tablet is as safe and effective as daily dosing. Outcomes are improved when the total weekly dose provided during alternate-day dosing is equal to that given during daily dosing.

Eligibility

Relevant conditions:

Heroin Dependence

Opioid-Related Disorders

If you aren't sure if you meet the criteria above speak to your healthcare professional. Criteria may be updated but not reflected here, do not hesitate to contact the study if you think are close to fitting criteria.

locations

Contact Information

Overall Contact

No valid contacts available

Data sourced from ClinicalTrials.gov